We then applied the risk factor changes from the SURMOUNT-1 trial tirzepatide 15 mg group (as shown in Table S4 in the Appendix of the SURMOUNT-1 publication [11]) to estimate the post-treatment 10-year CVD risk similarly with these equations
The most common side effects are gastrointestinal (such as nausea, vomiting, or diarrhea), and your physician also watches for less common but serious effects such as pancreatitis
For travel periods exceeding 48 hours without refrigeration access, discuss alternative arrangements with your provider
From August to September of 2025, 486 new plaintiffs joined the group lawsuit against GLP-1 drug manufacturers, bringing the total to 2,676
if you experience chest pain, shortness of breath, or fainting, seek emergency evaluation